CDKN2A and cancer: Sp1 enables the cancer cells to avoid senescence and achieve replication immortalization through the genes encoding the cyclin-dependent kinase (CDK) inhibitor p16 (Ink4a), p53, and various factors involved in maintaining telomeres, including telomerase.